PPIL2 suppression induces cellular senescence and inhibits proliferation in hepatocellular carcinoma via c-myc/p21 axis
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2026.113109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Xiaojing Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China; School of Basic Medical …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Cell Proliferation, Cellular Senescence, Cyclophilins. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Commission of the People's Republic of China, Southwest Medical University, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the most prevalent primary malignancy of the liver characterized by high mortality rates. While peptidylprolyl isomerase-like two (PPIL2) has been implicated in various malignancies, its functional contribution to HCC progression and the underlying molecular mechanisms remain poorly defined. In this study, we observed significant upregulation of PPIL2 in HCC tissues, which correlated with unfavorable patient prognosis. Functional assays showed that PPIL2 knockdown markedly inhibited HCC cell proliferation by inducing cell cycle arrest and cellular senescence. Mechanistically, PPIL2 depletion led to reduced c-Myc protein levels and a concomitant induction of p21. Critically, the tumor-suppressive effects induced by PPIL2 silencing were partially rescued upon c-Myc overexpression, confirming that PPIL2 exerts its oncogenic function predominantly through a c-Myc-dependent pathway. Furthermore, PPIL2 deficiency effectively hindered tumor growth in a xenograft mouse model. Collectively, these findings identify the PPIL2/c-Myc/p21 axis as a critical regulator of HCC proliferation and senescence, positioning PPIL2 as a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China; School of Basic Medical Sciences, State Key Laboratory of Southwestern Chinese Medicine Resour…
- Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
- Department of Clinical Medicine, Southwest Medical University, Luzhou, China.
- Clinical Research Institute, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
- Department of Oncology, The Second Peoples' Hospital of Yibin, Yibin, China. Electronic address: zhangjinghgy@163.com.
- Department of Oncology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China…
Förderung
- National Health Commission of the People's Republic of China
- Southwest Medical University
- Natural Science Foundation of Sichuan Province
- Sichuan Medical Association
- National Science and Technology Major Project
- Yibin Science and Technology Planning Program
Zitieren
APA
Chen, X., Zhang, Z., Yan, Z., Du, X., Wang, J., Liu, X., Hu, L., Kuang, Z., He, K., Zhang, J., & Han, Y. (2026). PPIL2 suppression induces cellular senescence and inhibits proliferation in hepatocellular carcinoma via c-myc/p21 axis. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113109
Vancouver
Chen X, Zhang Z, Yan Z, Du X, Wang J, Liu X, et al. PPIL2 suppression induces cellular senescence and inhibits proliferation in hepatocellular carcinoma via c-myc/p21 axis. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113109
BibTeX
@article{Chen2026,
author = {Chen, Xiaojing and Zhang, Zhiyao and Yan, Zihan and Du, Xinrui and Wang, Jihong and Liu, Xin and Hu, Lanxin and Kuang, Zhiyan and He, Kun and Zhang, Jing and Han, Yunwei},
title = {PPIL2 suppression induces cellular senescence and inhibits proliferation in hepatocellular carcinoma via c-myc/p21 axis},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.113109}
}
EUVIMED